Covestor
RLAY icon

Covestor’s Relay Therapeutics RLAY Stock Holding History

Covestor’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$0 Sell
23
-34
-60% -$651 ﹤0.01% 2754
2026
Q2 		$1K Buy
57
+40
+235% +$581 ﹤0.01% 2307
2026
Q1 		$0 Sell
17
-7
-29% -$63 ﹤0.01% 2696
2025
Q4 		$0 Hold
24
– – ﹤0.01% 2667
2025
Q3 		$0 Hold
24
– – ﹤0.01% 2689
2025
Q2 		$0 Sell
24
-2
-8% -$6 ﹤0.01% 2670
2025
Q1 		$0 Buy
26
+15
+136% +$59 ﹤0.01% 2650
2024
Q4 		$0 Hold
11
– – ﹤0.01% 2653
2024
Q3 		$0 Hold
11
– – ﹤0.01% 2669
2024
Q2 		$0 Hold
11
– – ﹤0.01% 2666
2024
Q1 		$0 Sell
11
-1
-8% -$10 ﹤0.01% 2650
2023
Q4 		$0 Buy
12
+4
+50% +$34 ﹤0.01% 2620
2023
Q3 		$0 Sell
8
-1
-11% -$11 ﹤0.01% 2611
2023
Q2 		$0 Hold
9
– – ﹤0.01% 2560
2023
Q1 		$0 Hold
9
– – ﹤0.01% 2484
2022
Q4 		$0 Sell
9
-1
-10% -$19 ﹤0.01% 2507
2022
Q3 		$0 Sell
10
-1
-9% -$22 ﹤0.01% 2486
2022
Q2 		$0 Sell
11
-4
-27% -$86 ﹤0.01% 2287
2022
Q1 		$0 Sell
15
-4
-21% -$97 ﹤0.01% 2388
2021
Q4 		$1K Buy
+19
New +$600 ﹤0.01% 1902

Other funds holding RLAY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $57.2B AUM 42.49% 1-Year Est. Return
Alphabet Inc
Alphabet Inc Mountain View, California $88.3B AUM 46.07% 1-Year Est. Return
TGY2IT
Timothy G. Youngquist 2020 Irrevocable Trust Fort Myers, Florida $530M AUM 95.29% 1-Year Est. Return
Congress Asset Management
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.39% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Jupiter Asset Management
Jupiter Asset Management London, United Kingdom $21.4B AUM 19.74% 1-Year Est. Return

Covestor's RLAY Position: Q3 2026 in Review

Covestor reduced its Relay Therapeutics (RLAY) stake by 60% in Q3 2026, selling an estimated $651 and leaving 23 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2754.

Covestor first reported a position in RLAY in Q4 2021 and has held it in 20 quarters since. The position peaked at $1K in Q2 2026. 107 funds tracked by Wall St. Rank hold RLAY as of Q3 2026.

  • Covestor held 23 shares of Relay Therapeutics worth $0 as of Q3 2026.
  • Covestor sold 34 Relay Therapeutics shares in Q3 2026, an estimated $651.
  • Relay Therapeutics made up ﹤0.01% of Covestor's portfolio in Q3 2026, its #2754 holding.
  • Covestor first reported a position in Relay Therapeutics in Q4 2021 and has held it in 20 quarters since.
  • Covestor's Relay Therapeutics position peaked at $1K in Q2 2026.
  • 107 funds tracked by Wall St. Rank held Relay Therapeutics as of Q3 2026.

Based on Covestor's 13F filing for Q3 2026, filed 30 Oct 2026.